Autoantibody Profile of Egyptian Juvenile Systemic Lupus Erythematosus Patients and Its Association with Clinical Characteristics and Disease Activity

References

• Wang F, Zhang W, Wang S, et al. Protective effects of antimalarial in Chinese patients with systemic lupus erythematous. Ann Rhum Dis. 2018;78–e80. doi:10.1136/annrheumdis-2018-213819
   Google Scholar
• Groot N, De Graeff N, Avcin T, et al. European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus. The SHARE initiative. Ann Rheum Dis. 2017;76:1788–1796. doi:10.1136/annrheumdis-2016-210960
   PubMed Web of Science ®Google Scholar
• Nalbanti P, Stefanidou S, Alfantaki S, et al. A 5-year multicenter comparative study between patients with juvenile and adult-onset systemic lupus erythematosus. Pediatriki. 2012;72–85. Greek.
   Google Scholar
• Zharkova O, Celhar T, Cravens PD, Satterthwaite AB, Fairhurst AM. Davis LS. Pathways leading to an immunological disease: systemic lupus erythematosus. Rheumatology (Oxford). 2017;56(1):i55–i66. doi:10.1093/rheumatology/kew427
   Web of Science ®Google Scholar
• Phan TG, Wong RC. Adelstein S Autoantibodies to extractable nuclear antigens: making detection and interpretation more meaningful. Clin Diagn Lab Immunol. 2002;9(1):1–7.
   Google Scholar
• Sallai K, Nagy E, Derfalvy B, Müzes G, Gergely P. Antinucleosome antibodies and decreased deoxyribonuclease activity in sera of patients with systemic lupus erythematosus. Clin Diagn Lab Immunol. 2005;12:56–59.
   PubMedGoogle Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725. doi:10.1002/art.1780400928
   PubMed Web of Science ®Google Scholar
• Petri M, Orabi A, Alarcón GS, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64:2677–2686. doi:10.1002/art.34473
   PubMed Web of Science ®Google Scholar
• Rekvig OP. The anti-DNA antibody: origin and impact, dogmas and controversies. Nat Rev Rheumatol. 2015;11(9):530–540. doi:10.1038/nrrheum.2015.69
   PubMed Web of Science ®Google Scholar
• Linnik MD, Hu JZ, Heilbrunn KR, Strand V, Hurley FL. Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus. Arthritis Rheum. 2005;52(4):1129–1137. doi:10.1002/art.20980
   PubMed Web of Science ®Google Scholar
• Emad Y, Gheita T, Darweesh H, et al. Antibodies to extractable nuclear antigens (ENAS) in systemic lupus erythematosus patients: correlations with clinical manifestations and disease activity. Reumatismo. 2018;70:85–91. doi:10.4081/reumatismo.2018.1027
   Web of Science ®Google Scholar
• Weening JJ, D’Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65:521–530. doi:10.1111/j.1523-1755.2004.00443.x
   PubMed Web of Science ®Google Scholar
• Von Mühlen CA, Tan EM. Autoantibodies in the diagnosis of systemic lupus erythematosus. Semin Arthritis Rheum. 1995;5:323–358.
   Web of Science ®Google Scholar
• Emlen W, O’Neil L. Clinical significance and interpretation of anti-nuclear antibodies: comparison of detection with immunofluorescence and enzyme linked immunosorbent assays. Arthris Rheum. 1997;40:1612–1618. doi:10.1002/art.1780400910
   PubMed Web of Science ®Google Scholar
• Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29:288–291.
   PubMed Web of Science ®Google Scholar
• Ambrose N, Morgan TA, Galloway J, Ionnoau Y, Beresford MW, Isenberget DA. Differences in disease phenotype and severity in SLE across age groups. Lupus. 2016;25:1542–1550. doi:10.1177/0961203316644333
   PubMed Web of Science ®Google Scholar
• Balci S, Ekinci RMK, Bayazit AK, et al. Juvenile systemic lupus erythematosus: a single-center experience from southern Turkey. Clin Rheumatol. 2019;38:1459–1468. doi:10.1007/s10067-019-04433-4
   Web of Science ®Google Scholar
• Kini S, Bhat RY, Thunga C, et al. Clinical and immunological spectrum of systemic lupus erythematosus in children. J Nepal Paediatr Soc. 2020;40:14–20. doi:10.3126/jnps.v40i1.28460
   Google Scholar
• Gomes KB, Islam MI, Rahman S. Autoantibody profile and its association with clinical presentation of pediatric SLE patients. Am J Pediatr. 2019;5:178–182. doi:10.11648/j.ajp.20190504.11
   Google Scholar
• Torrente-Segarraa V, Salman-Monteb TC, Figueroac IR. Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER). Semin Arthritis Rheum. 2020;50:657–662. doi:10.1016/j.semarthrit.2020.05.016
   Web of Science ®Google Scholar
• Kosaraju K, Shenoy S, Suchithra UA. Cross-sectional hospital based study of autoantibody profile and clinical manifestations in south Indian patients. Indian J Med Microbiol. 2010;28:245–247.
   Web of Science ®Google Scholar
• Srivastava P, Abujam B, Misra R, Lawrence A, Agarwal V, Aggarwal A. Outcome of lupus nephritis in childhood onset SLE in North and Central India!: single-centre experience over 25 years. Lupus. 2015;1:1–11.
   Google Scholar
• Andy SK, Kandasamy E. Clinical profile of systemic lupus erythematosus among children less than 12 years. Int J Contemp Pediatr. 2018;5:343–349. doi:10.18203/2349-3291.ijcp20180458
   Google Scholar
• Sahin S, Adrovic A, Barut K, et al. Juvenile systemic lupus erythematosus in Turkey: demographic, clinical and laboratory features with disease activity and outcome. Lupus. 2018;27:514–519. doi:10.1177/0961203317747717
   Web of Science ®Google Scholar
• Hiraki LT, Benseler SM, Tyrrell PN, Hebert D, Harvey E, Silverman ED. Clinical and laboratory characteristics and long term outcome of pediatric systemic lupus erythematosus: a longitudinal study. J Pediatr. 2008;152:550–556. doi:10.1016/j.jpeds.2007.09.019.
   PubMed Web of Science ®Google Scholar
• Abdel-Hafez MA, Abdel-Nabi H. Juvenile systemic lupus erythematosus: onset patterns and short-term outcome in Egyptian children, a single-center experience. Lupus. 2015;24:1455–1461. doi:10.1177/0961203315598016
   Web of Science ®Google Scholar
• Dung NT, Loan HT, Nielsen S, Zak M, Petersen FK. Juvenile systemic lupus erythematosus onset patterns in Vietnamese children: a descriptive study of 45 children. Pediatr Rheumatol Online J. 2012;10:38. doi:10.1186/1546-0096-10-38
   Web of Science ®Google Scholar
• Kim H, Levy DM, Silverman ED, et al. A comparison between childhood and adult onset systemic lupus erythematosus adjusted for ethnicity from the 1000 Canadian Faces of Lupus Cohort. Rheumatology. 2019;58:1393–1399. doi:10.1093/rheumatology/kez006
   Web of Science ®Google Scholar
• Dipti TR, Azam MS, Sattar MH, Rahman SA. Detection of antinuclear antibody in childhood rheumatic diseases by immunofluorescence assay and enzyme immunoassay. Bangladesh J Child Health. 2011;35:49–52. doi:10.3329/bjch.v35i2.10355
   Google Scholar
• Weiss JE. Pediatric systemic lupus erythematosus: more than a positive antinuclear antibody. Pediatr Rev. 2012;33:62–74. doi:10.1542/pir.33-2-62
   PubMedGoogle Scholar
• Migliorini P, Baldini C, Rocci V, Bombardieri S. Anti-Sm and anti-RNP antibodies. Autoimmunity. 2005;38:47–54. doi:10.1080/08916930400022715
   PubMed Web of Science ®Google Scholar
• Liphus BL, Kiss MHB, Goldberg AC. HLA –DRB1 alleles in juvenile onset systemic lupus erythematosus: renal histologic class correlations. Braz J Med Biol Res. 2007;40:591–597. doi:10.1590/S0100-879X2007000400019
   Web of Science ®Google Scholar
• Kadiyala R, Kini PG, Aroor S, Kumar S, Moras K. Clinico-immunological profile and outcome of childhood systemic lupus Erythematosus. Sri Lanka J Child Health. 2019;48:201–207. doi:10.4038/sljch.v48i3.8753
   Google Scholar
• Jurencák R, Fritzler M, Tyrrell P, Hiraki L, Benseler S, Silverman E. Autoantibodies in pediatric systemic lupus erythematosus! Ethnic grouping, cluster analysis, and clinical correlations. J Rheumatol. 2009;36:416–421. doi:10.3899/jrheum.080588
   PubMed Web of Science ®Google Scholar
• Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum. 2004;34(2):501–537.
   PubMed Web of Science ®Google Scholar
• Cortes-Hernandez J, Ordi-Ros J, Labrador M, et al. Antihistone and anti-double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus. Am J Med. 2004;116(3):165–173. doi:10.1016/j.amjmed.2003.08.034
   PubMed Web of Science ®Google Scholar
• Hoffman IEA, Peene I, Meheus L, et al. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis. 2004;63:1155–1158. doi:10.1136/ard.2003.013417
   PubMed Web of Science ®Google Scholar
• Marina M, Melissa FE, Paulo HRN, Thelma LS. Anti RNP in systemic lupus erythematosus. Acta Reumatol Port. 2013;38:136–137.
   Web of Science ®Google Scholar
• Morasis SA, Isenberg DA. A study of the influence of ethnicity on serology and clinical features in lupus. Lupus. 2017;26:17–26. doi:10.1177/0961203316645204
   Web of Science ®Google Scholar
• Thompson D, Juby A, Davis P. The clinical significance of autoantibody profiles in patients with systemic lupus erythematosus. Lupus. 1993;2:15–19. doi:10.1177/096120339300200104
   PubMed Web of Science ®Google Scholar
• Ahn SS, Min JS, Yoo J, Lee SW, Song JJ, Park YB. Anti-Smith antibody is associated with disease activity in patients with new-onset systemic lupus erythematosus. Rheumatol Int. 2019;39:1937–1944. doi:10.1007/s00296-019-04445-y
   Web of Science ®Google Scholar
• Ahn SS, Yoo BW, Song JJ, Park YB, Lee SK, Lee SW. Anti-Sm is associated with the early poor outcome of lupus nephritis. Int J Rheum Dis. 2016;19:897–902. doi:10.1111/1756-185X.12880
   PubMed Web of Science ®Google Scholar
• Tapanes FJ, Vasquez M, Ramirez R, et al. Cluster analysis of antinuclear autoantibodies in the prognosis of SLE nephropathy: are anti-extractable nuclear antibodies protective? Lupus. 2000;9:437–444. doi:10.1191/096120300678828604
   PubMed Web of Science ®Google Scholar
• Frodlund M, Dahlstrom O, Kastbom A, Skogh T, Sjowall C. Association between antinuclear antibody staining patterns and clinical features of systemic lupus erythematosus: analysis of a regional Swedish register. BMJ Open. 2013;3:10. doi:10.1136/bmjopen-2013-003608
   Web of Science ®Google Scholar
• Li PH, Wong WH, Lee TL, et al. Relationship between autoantibody clustering and clinical subsets in SLE: cluster and association analyses in Hong Kong Chinese. Rheumatology (Oxford). 2013;52:337–345. doi:10.1093/rheumatology/kes261
   Web of Science ®Google Scholar
• Rao L, Liu G, Li C, et al. Specificity of anti-SSB as a diagnostic marker for the classification of systemic lupus erythematosus. Exp Ther Med. 2013;5(6):1710–1714. doi:10.3892/etm.2013.1051
   Web of Science ®Google Scholar
• Agarwal S, Harper J, Kiely PD. Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus. Lupus. 2009;18:407–412. doi:10.1177/0961203308097784
   Web of Science ®Google Scholar